D-0574-2025 Class II Ongoing
FDA drug recall D-0574-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Aug 5, 2025 and is designated Class II. Reason for recall: Presence of foreign substance: identified as aluminum. The recall status is ongoing. Affected quantity: 11,328 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 13, 2025
- Initiation Date
- Aug 5, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,328 bottles
Product description
Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01
Reason for recall
Presence of foreign substance: identified as aluminum.
Distribution pattern
USA Nationwide
Code information
Lot # P3314, Exp 11/30/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0574-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026